Related Experiment Video
Updated: May 4, 2026
08:45
New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
Published on: June 27, 2025
1.9K
The patient presenting with decompensated cirrhosis
1Consultant Gastroenterologist and Hepatologist, Frimley Park Hospital NHS Foundation Trust.
Acute Medicine
|December 24, 2013
Summary
Rising liver disease in the UK necessitates prompt management of complications like sepsis and kidney injury. Early assessment and reassessment of prognosis, particularly in alcoholic liver disease, are crucial for improved patient outcomes.
Area of Science:
- Hepatology
- Internal Medicine
- Acute Care
Background:
- Increasing incidence of liver disease in the UK.
- Patients with liver disease present to acute medical units with life-threatening complications.
- Traditional prognosis assessment may be inaccurate for alcohol-related liver disease.
Purpose of the Study:
- To summarize key complications of decompensated cirrhosis.
- To outline early management strategies for these complications.
- To introduce the 'RING Liver' care system for targeted patient management.
Main Methods:
- Review of important complications of decompensated cirrhosis.
- Summary of current early management protocols.
- Presentation of the 'RING Liver' framework (Renal failure, Infection, Nutrition, Gastrointestinal bleeding and transit, Liver dysfunction/transplantation).
Main Results:
- Early recognition and management of sepsis, kidney injury, and bleeding improve outcomes.
- Prognosis reassessment after 48 hours of organ support offers greater accuracy.
- The 'RING Liver' system provides a structured approach to care.
Conclusions:
- Comprehensive assessment is vital for managing acute liver disease complications.
- A reassessment of prognosis after initial organ support is recommended.
- The 'RING Liver' system facilitates targeted care and identifies patients for tertiary transfer.
More Related Videos
Related Concept Videos
01:23Cirrhosis I: Introduction
28
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
28
01:24Cirrhosis II: Pathophysiology
42
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
42
01:28Esophageal Varices-II: Clinical Features and Management
884
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
884
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
382
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382
01:22Portal Hypertension
50
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
50
01:26Diseases of the Liver and Gallbladder
2.1K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K